OpenEvidence CTO Zachary Ziegler said, at the STAT Breakthrough Summit West, that the company is looking beyond physician users.
Vetenskapsnyheter
Are too many symptoms blamed on perimenopause? Two experts weigh in on the “First Opinion Podcast.”
23andMe is partnering with HealthEx to allow users to import their medical records, the company said Tuesday at STAT Breakthrough Summit West.
Former Stanford President Marc Tessier-Lavigne responded publicly for the first time, at a STAT event Tuesday, to allegations in a new book about why he was forced to resign.
Trump's cuts to foreign aid likely hampered the detection of the Ebola outbreak and the response to it.
Virginia's governor vetoed a closely watched effort to create an advisory panel to lower prescription drug costs.
A new analysis shows how some clinicians are cashing in on a new process designed to protect patients from surprise bills.
The parents of Jorie Krause told the audience at STAT's Breakthrough Summit about how AI helped their daughter who was born with a rare disease.
Most Canadian medical societies lack comprehensive policies governing conflicts of interest, and many policies are generally fragmented and narrow in scope, according to a new analysis.
With the FDA facing upheaval and a series of personnel exits, former commissioner David Kessler sees an inflection point whereby the agency can now make a turn for the better.
A deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.
In this edition of STAT Health Tech: Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.
Maryland drug board to cap price of Ozempic, TrumpRx partners with Cuban, GoodRx, and more biotech news
The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
A new set of lists ranks drug company laboratories on two criteria: innovation and invention.
Affordable Care Act changes, drinking while pregnant, and more health news from Morning Rounds
Britain embraces a Massachusetts experiment on tobacco regulation — just as the commonwealth might roll it back.
“On paper, I have insurance coverage. In real life, I don’t have access. That’s what I call ‘ghost approval,’” writes patient advocate Payton Herres.
More than 1 in 8 pregnant women report drinking. Doctors warn fetal alcohol disorders may be more common than many realize, perhaps more common than autism.
Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the price of Ozempic.
Trump's drug discount platform adds 600 generic medications via major online pharmacies.
With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.
The new plans could leave patients on the hook for more of their health care costs.
Hospital execs worked in secret on the deal for two years.
The China question, FDA leadership shakeups, and other biotech news from The Readout